RML Hospital's resident doctors association apprehensive about Covaxin
The Covaxin controversy has been around ever since the government gave the shot an emergency approval under a 'clinical trial mode'16-01-2021
16-01-2021
Delhi geared up for COVID-19 vaccination roll-out tomorrow at 81 sites
The 81 sites include six central government facilities -- AIIMS, Safdarjung Hospital, RML Hospital, Kalawati Saran Children Hospital and two ESI hospitals.15-01-2021
RANE (MADRAS) LTD. - 532661 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of duplicate share certificate11-01-2021
RANE (MADRAS) LTD. - 532661 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S Subha ShreeDesignation :- Company Secretary and Compliance Officer08-01-2021
RANE (MADRAS) LTD. - 532661 - Shareholding for the Period Ended January 07, 2021
Rane (Madras) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended January 07, 2021. For more details, kindly Click here08-01-2021
RANE (MADRAS) LTD. - 532661 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rane Holdings Ltd08-01-2021
RANE (MADRAS) LTD. - 532661 - Announcement under Regulation 30 (LODR)-Conversion of Securities
The issue and allotment of committee of the board of directors of the Company at their meeting held today has allotted 11,61,440 equity shares of face value of Rs.10/- each, as fully paid-up pursuant to exercise of entire balance outstanding 11,61,440 warrants out of 17,42,160 warrants allotted by RML on December 18, 2019, on preferential basis to Rane Holdings Limited (holding Company). The allotment has been made for cash, upon receipt of entire balance of 75% of issue price i.e.,Rs. 25,00,00,000.00 (warrant exercise price). These equity shares now allotted, shall rank pari passu in all respects with the existing equity shares, including dividend, if any. The details required under Regulation 30 of SEBI (Listing Obligations and Disclosure) Requirements) Regulations, 2015 read with SEBI circular No. CIR/ CFD/CMD/4/2015 dated September 09, 2015 is enclosed in Annexure- A.07-01-2021
RANE (MADRAS) LTD. - 532661 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform that the details of securities dematerialized / rematerialized during the quarter ended December 31, 2020, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 have been furnished by our Registrar and Share Transfer Agent to all the Stock Exchanges, where the shares of the Company are listed (copy enclosed). We hereby confirm and certify that: a.The securities comprised in the said certificates(s) have been listed on the stock exchanges or exchanges were the earlier issued securities were listed; and b. The certificates have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within 15 days of its receipt.04-01-2021
RANE (MADRAS) LTD. - 532661 - Shareholding for the Period Ended December 31, 2020
Rane (Madras) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here04-01-2021
RANE (MADRAS) LTD. - 532661 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate(s)31-12-2020